US Bancorp’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13M Buy
54,625
+1,398
+3% +$291K 0.01% 390
2026
Q1
$11.2M Buy
53,227
+235
+0.4% +$50.6K 0.01% 393
2025
Q4
$10.9M Buy
52,992
+12,955
+32% +$2.44M 0.01% 416
2025
Q3
$6.28M Sell
40,037
-3,448
-8% -$533K 0.01% 550
2025
Q2
$7.31M Sell
43,485
-629
-1% -$93.4K 0.01% 492
2025
Q1
$6.08M Buy
44,114
+292
+0.7% +$37.2K 0.01% 531
2024
Q4
$5.18M Sell
43,822
-1,436
-3% -$168K 0.01% 576
2024
Q3
$5M Sell
45,258
-961
-2% -$100K 0.01% 585
2024
Q2
$4.54M Sell
46,219
-1,911
-4% -$195K 0.01% 597
2024
Q1
$5.39M Sell
48,130
-541
-1% -$58.4K 0.01% 562
2023
Q4
$4.91M Sell
48,671
-318
-0.6% -$31.6K 0.01% 578
2023
Q3
$4.25M Sell
48,989
-3,820
-7% -$345K 0.01% 576
2023
Q2
$4.99M Sell
52,809
-16,103
-23% -$1.36M 0.01% 548
2023
Q1
$5.2M Sell
68,912
-1,375
-2% -$104K 0.01% 542
2022
Q4
$5.4M Sell
70,287
-5,051
-7% -$384K 0.01% 525
2022
Q3
$5.02M Sell
75,338
-5,354
-7% -$339K 0.01% 518
2022
Q2
$4.22M Sell
80,692
-2,971
-4% -$169K 0.01% 566
2022
Q1
$4.74M Sell
83,663
-7,454
-8% -$399K 0.01% 581
2021
Q4
$4.69M Sell
91,117
-8,938
-9% -$438K 0.01% 603
2021
Q3
$4.95M Sell
100,055
-5,777
-5% -$313K 0.01% 562
2021
Q2
$6.04M Sell
105,832
-1,768
-2% -$103K 0.01% 530
2021
Q1
$6.54M Sell
107,600
-4,813
-4% -$266K 0.01% 499
2020
Q4
$6.02M Buy
112,413
+6,368
+6% +$330K 0.01% 486
2020
Q3
$4.98M Sell
106,045
-2,204
-2% -$113K 0.01% 496
2020
Q2
$5.65M Sell
108,249
-1,712
-2% -$88.3K 0.01% 458
2020
Q1
$5.27M Sell
109,961
-663
-0.6% -$34.4K 0.02% 431
2019
Q4
$5.6M Sell
110,624
-7,609
-6% -$393K 0.01% 483
2019
Q3
$5.58M Sell
118,233
-6,532
-5% -$298K 0.02% 483
2019
Q2
$5.88M Sell
124,765
-9,464
-7% -$437K 0.02% 473
2019
Q1
$6.46M Sell
134,229
-32,613
-20% -$1.63M 0.02% 432
2018
Q4
$7.44M Sell
166,842
-11,022
-6% -$575K 0.02% 390
2018
Q3
$9.6M Sell
177,864
-10,016
-5% -$513K 0.03% 375
2018
Q2
$9.17M Sell
187,880
-26,079
-12% -$1.48M 0.03% 370
2018
Q1
$13.4M Sell
213,959
-17,779
-8% -$1.22M 0.04% 298
2017
Q4
$14.2M Sell
231,738
-70,989
-23% -$4.39M 0.04% 293
2017
Q3
$20.3M Sell
302,727
-105,268
-26% -$7.44M 0.06% 237
2017
Q2
$31.8M Sell
407,995
-400,385
-50% -$30.2M 0.11% 171
2017
Q1
$65.9M Buy
808,380
+104,665
+15% +$8.24M 0.23% 102
2016
Q4
$50.6M Sell
703,715
-13,190
-2% -$954K 0.18% 114
2016
Q3
$55.7M Buy
716,905
+103,036
+17% +$8.33M 0.21% 104
2016
Q2
$47.9M Buy
613,869
+114,452
+23% +$9.12M 0.18% 114
2016
Q1
$40.9M Buy
499,417
+131,839
+36% +$10.7M 0.16% 124
2015
Q4
$32.8M Buy
367,578
+89,425
+32% +$7.59M 0.13% 148
2015
Q3
$21.4M Buy
278,153
+88,480
+47% +$7.39M 0.09% 195
2015
Q2
$15.9M Buy
189,673
+11,414
+6% +$1.01M 0.06% 257
2015
Q1
$16.1M Sell
178,259
-1,553
-0.9% -$134K 0.06% 253
2014
Q4
$14.5M Buy
179,812
+2,777
+2% +$219K 0.06% 267
2014
Q3
$13.3M Buy
177,035
+5,249
+3% +$382K 0.05% 264
2014
Q2
$11.8M Buy
171,786
+15,618
+10% +$1.06M 0.05% 287
2014
Q1
$10.9M Buy
156,168
+16,892
+12% +$1.17M 0.04% 295
2013
Q4
$9.3M Sell
139,276
-18,529
-12% -$1.13M 0.04% 318
2013
Q3
$8.23M Buy
157,805
+3,946
+3% +$200K 0.04% 326
2013
Q2
$7.26M Buy
+153,859
New +$7.03M 0.03% 337

Other funds holding CAH

US Bancorp's CAH Position: Q2 2026 in Review

US Bancorp increased its Cardinal Health (CAH) stake by 2.6% in Q2 2026, buying an estimated $291K and bringing the position to 54,625 shares worth $13M. The position accounts for 0.01% of the portfolio, ranked #390.

US Bancorp first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. The position peaked at $65.9M in Q1 2017. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • US Bancorp held 54,625 shares of Cardinal Health worth $13M as of Q2 2026.
  • US Bancorp bought 1,398 Cardinal Health shares in Q2 2026, an estimated $291K.
  • Cardinal Health made up 0.01% of US Bancorp's portfolio in Q2 2026, its #390 holding.
  • US Bancorp first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
  • US Bancorp's Cardinal Health position peaked at $65.9M in Q1 2017.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.